148 related articles for article (PubMed ID: 33537822)
1. MicroRNA‑199a‑3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1.
He Y; Yu X; Tang Y; Guo Y; Yuan J; Bai J; Yao T; Wu X
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537822
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑15a‑5p‑targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.
Chen X; Cao R; Liu H; Zhang T; Yuan X; Xu S
Int J Mol Med; 2020 Oct; 46(4):1301-1310. PubMed ID: 32945353
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑199a‑3p suppresses high glucose‑induced apoptosis and inflammation by regulating the IKKβ/NF‑κB signaling pathway in renal tubular epithelial cells.
Zhang R; Qin L; Shi J
Int J Mol Med; 2020 Dec; 46(6):2161-2171. PubMed ID: 33125105
[TBL] [Abstract][Full Text] [Related]
5. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
[TBL] [Abstract][Full Text] [Related]
7. miR‑199a‑3p/Sp1/LDHA axis controls aerobic glycolysis in testicular tumor cells.
Zhou S; Min Z; Sun K; Qu S; Zhou J; Duan H; Liu H; Liu X; Gong Z; Li D
Int J Mol Med; 2018 Oct; 42(4):2163-2174. PubMed ID: 30015851
[TBL] [Abstract][Full Text] [Related]
8. Interaction of YAP1 and mTOR promotes bladder cancer progression.
Xu M; Gu M; Zhou J; Da J; Wang Z
Int J Oncol; 2020 Jan; 56(1):232-242. PubMed ID: 31789387
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
10. Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma.
Cho SY; Kim K; Park MS; Jang MY; Choi YH; Han S; Shin HM; Chung C; Han HY; Yang JB; Ko YB; Yoo HJ
Oncol Rep; 2017 May; 37(5):2620-2632. PubMed ID: 28339095
[TBL] [Abstract][Full Text] [Related]
11. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
Liu B; Zhang J; Yang D
J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
[TBL] [Abstract][Full Text] [Related]
12. HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.
Han T; Chen T; Chen L; Li K; Xiang D; Dou L; Li H; Gu Y
Cell Death Dis; 2023 Sep; 14(9):606. PubMed ID: 37709768
[TBL] [Abstract][Full Text] [Related]
13. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
Feng S; Sun H; Zhu W
Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
16. Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway.
Wei X; Jia Y; Lou H; Ma J; Huang Q; Meng Y; Sun C; Yang Z; Li X; Xu S; Yang X; Ji T; Gao Q
Oncol Rep; 2019 Dec; 42(6):2768-2776. PubMed ID: 31638241
[TBL] [Abstract][Full Text] [Related]
17. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
Wu D; Liu C; Hong L
Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
[TBL] [Abstract][Full Text] [Related]
18. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.
Lv T; Song K; Zhang L; Li W; Chen Y; Diao Y; Yao Q; Liu P
Biochem Cell Biol; 2018 Oct; 96(5):663-671. PubMed ID: 29561664
[TBL] [Abstract][Full Text] [Related]
19. MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells.
Zhang G; Wang J; Zheng R; Song B; Huang L; Liu Y; Hao Y; Bai X
Technol Cancer Res Treat; 2020; 19():1533033820927011. PubMed ID: 32462982
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
